We have shown previously that Arf6 activity greatly contributes to the invasive and metastatic activities of breast cancer cells, when Arf6 is activated by GEP100/BRAG2 [10] and employs AMAP1/DDEF1/ASAP1 as a downstream factor [11], [12], [13]. The gene discussed is ASAP1; the disease is breast cancer.